beta
ABLX
Ablynx NV
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Ablynx NV is a clinical-stage biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments.
Market Cap: 3.36 Billion
Primary Exchange: Nasdaq Global Select
Website: http://www.ablynx.com
Shares Outstanding: 75.1 Million
Float: 75.1 Million
Dividend: 0.0 (0.0%)
Beta: 14.372817
Sector: Healthcare
Industry: Biotechnology
Ethical Flags
Longest drawdown: 175 trading days
From: 2018-04-18 To: 2018-06-12
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|